UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.48B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$690M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$588M |
| 4 |
Truist Financial
TFC
|
+$532M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.3B |
| 2 |
Alibaba
BABA
|
+$771M |
| 3 |
AABA
Altaba Inc
AABA
|
+$759M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$503M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.31% |
| 2 | Technology | 9.89% |
| 3 | Financials | 7.42% |
| 4 | Healthcare | 6.84% |
| 5 | Consumer Discretionary | 5.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HDV
326
iShares Core High Dividend ETF
HDV
$15.3B
| $152M | 0.05% |
7,729,405
+289,425
| +4% | +$5.52M |
|
327
Alerian MLP ETF
AMLP
$12.9B
| $149M | 0.05% |
3,513,795
-1,501,340
| -30% | -$63M |
|
328
Invesco S&P 500 Low Volatility ETF
SPLV
$7.01B
| $149M | 0.05% |
2,552,970
+472,784
| +23% | +$27.1M |
|
329
CALL
iShares Biotechnology ETF
IBB
$10.7B
| $148M | 0.05% |
1,229,900
+845,900
| +220% | +$94.4M |
|
330
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.2B
| $147M | 0.05% |
1,236,558
+59,331
| +5% | +$6.84M |
|
331
iShare MSCI Eurozone ETF
EZU
$9.59B
| $147M | 0.05% |
3,509,127
+179,086
| +5% | +$7.25M |
|
332
CALL
IQVIA
IQV
$44.5B
| $147M | 0.05% |
+951,700
| New | +$139M |
|
333
Waste Management
WM
$82.6B
| $146M | 0.05% |
1,284,179
+92,098
| +8% | +$10.4M |
|
334
iShares Short-Term National Muni Bond ETF
SUB
$11.7B
| $146M | 0.05% |
1,364,306
+91,370
| +7% | +$9.74M |
|
|
RDS.B
335
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $145M | 0.05% |
2,422,017
+4,871
| +0.2% | +$287K |
|
|
CZR
336
DELISTED
Caesars Entertainment Corporation
CZR
| $145M | 0.05% |
10,663,673
-6,646,355
| -38% | -$84.2M |
|
337
Vanguard Financials ETF
VFH
$12.7B
| $145M | 0.05% |
1,899,313
-38,047
| -2% | -$2.78M |
|
338
Caterpillar
CAT
$376B
| $144M | 0.05% |
977,815
-268,137
| -22% | -$37.4M |
|
|
ALXN
339
DELISTED
Alexion Pharmaceuticals
ALXN
| $144M | 0.05% |
1,334,393
+746,516
| +127% | +$79.8M |
|
|
FISV
340
Fiserv Inc
FISV
$24.4B
| $144M | 0.05% |
1,246,361
+635,842
| +104% | +$70.2M |
|
341
iShares Russell 2000 Growth ETF
IWO
$14.1B
| $144M | 0.05% |
670,309
+10,887
| +2% | +$2.21M |
|
342
American Water Works
AWK
$25.9B
| $143M | 0.05% |
1,167,677
-7,877
| -0.7% | -$955K |
|
343
Vanguard Tax-Exempt Bond Index Fund
VTEB
$44.6B
| $143M | 0.05% |
2,675,750
+169,166
| +7% | +$9.05M |
|
344
iShares MSCI China ETF
MCHI
$6.05B
| $141M | 0.05% |
2,194,132
-12,388
| -0.6% | -$741K |
|
345
PUT
Morgan Stanley
MS
$306B
| $139M | 0.05% |
2,720,400
-33,200
| -1% | -$1.57M |
|
|
346
CALL
UBS Group
UBS
$151B
| $139M | 0.05% |
11,032,373
-5,415,781
| -33% | -$64.4M |
|
347
Intuitive Surgical
ISRG
$139B
| $139M | 0.05% |
703,638
+26,064
| +4% | +$4.88M |
|
348
PUT
AbbVie
ABBV
$465B
| $138M | 0.05% |
1,558,100
+593,000
| +61% | +$49.2M |
|
349
CALL
AT&T
T
$173B
| $138M | 0.05% |
4,672,131
+1,464,079
| +46% | +$42.3M |
|
350
Applied Materials
AMAT
$383B
| $138M | 0.05% |
2,258,402
+266,555
| +13% | +$15M |
|
Similar funds
UBS Group's Q4 2019 Portfolio in Review
As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q4 2019 filing shows 807 new, 4,306 increased, 2,683 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 50% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
- UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
- UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
- UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
- UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
- UBS Group opened 807 new positions and closed 688 in Q4 2019.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.